Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Inventory (2022 - 2025)

Whitehawk Therapeutics (WHWK) reported Change in Inventory of -$170000.0 for Q1 2025, up 65.31% year-over-year from -$102839.5 in Q1 2024, and down 7.59% on a QoQ basis from -$158000.0 in Q4 2024.

Whitehawk Therapeutics (WHWK) has 4 years of Change in Inventory data on file, last reported at -$170000.0 in Q1 2025.

  • Quarterly Change in Inventory rose 65.31% year-over-year to -$170000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$170000.0 (up 84.77% YoY) and the FY2025 annual result came in at -$170000.0, up 84.77% from the prior year.
  • Change in Inventory eased to -$170000.0 in Q1 2025 per WHWK's latest filing, from -$158000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.2 million in Q4 2023 and bottomed at -$630000.0 in Q3 2024.
  • The 4-year median for Change in Inventory is $7000.0 (2022), against an average of $295384.6.
  • Peak annual rise in Change in Inventory reached 861.39% in 2023, while the deepest fall reached 4700.0% in 2023.
  • Tracing WHWK's Change in Inventory over 4 years: stood at $1.1 million in 2022, then soared by 97.43% to $2.2 million in 2023, then slumped by 107.1% to -$158000.0 in 2024, then decreased by 7.59% to -$170000.0 in 2025.
  • Per Business Quant, the three latest WHWK Change in Inventory figures stand at -$170000.0 (Q1 2025), -$158000.0 (Q4 2024), and -$630000.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 665.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 97.70 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -26.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.32 Mn
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 -170,000.00
Mar 31, 2025 -170,000.00
Dec 31, 2024 -158,000.00
Dec 31, 2024 -158,000.00
Sep 30, 2024 -630,000.00
Sep 30, 2024 -630,000.00
Jun 30, 2024 162,000.00
Jun 30, 2024 162,000.00
Mar 31, 2024 -490,000.00
Mar 31, 2024 -490,000.00
Dec 31, 2023 2.23 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 -322,000.00
Sep 30, 2023 -322,000.00
Jun 30, 2023 -580,000.00
Jun 30, 2023 -580,000.00
Mar 31, 2023 1.94 Mn
Mar 31, 2023 1.94 Mn
Dec 31, 2022 1.13 Mn
Dec 31, 2022 1.13 Mn
Sep 30, 2022 7,000.00
Sep 30, 2022 7,000.00
Jun 30, 2022 525,000.00
Jun 30, 2022 525,000.00
Mar 31, 2022 202,000.00
Mar 31, 2022 202,000.00